<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Effect of Adjuvant Chemotherapy on Survival in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Written by The ASCO Post on January 9, 2023

New research found that receiving adjuvant chemotherapy improved survival in patients with pancreatic adenocarcinoma who received curative-intent surgery.

Topics: Press Coverage

Related Stories